Guy Boivin

Guy Boivin

Université Laval

H-index: 92

North America-Canada

About Guy Boivin

Guy Boivin, With an exceptional h-index of 92 and a recent h-index of 42 (since 2020), a distinguished researcher at Université Laval,

His recent articles reflect a diverse array of research interests and contributions to the field:

A protectin DX (PDX) analog with in vitro activity against influenza A (H1N1) viruses

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses

Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir

The impact of trained immunity in respiratory viral infections

Leveraging influenza virus surveillance from 2012 to 2015 to characterize the burden of respiratory syncytial virus disease in Canadian adults≥ 50 years of age hospitalized …

Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada

Treatment of COVID-19 symptoms with over the counter (OTC) medicines used for treatment of common cold and flu

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria-and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs

Guy Boivin Information

University

Position

CHU de Québec and

Citations(all)

27141

Citations(since 2020)

7807

Cited By

21870

hIndex(all)

92

hIndex(since 2020)

42

i10Index(all)

308

i10Index(since 2020)

193

Email

University Profile Page

Google Scholar

Top articles of Guy Boivin

A protectin DX (PDX) analog with in vitro activity against influenza A (H1N1) viruses

Journal of Medical Virology

2024/3

Donald Poirier
Donald Poirier

H-Index: 22

Guy Boivin
Guy Boivin

H-Index: 43

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses

bioRxiv

2024/2/3

Jocelyne Piret
Jocelyne Piret

H-Index: 17

Guy Boivin
Guy Boivin

H-Index: 43

Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir

2024/1/18

Jocelyne Piret
Jocelyne Piret

H-Index: 17

Guy Boivin
Guy Boivin

H-Index: 43

The impact of trained immunity in respiratory viral infections

2024/1

Jocelyne Piret
Jocelyne Piret

H-Index: 17

Guy Boivin
Guy Boivin

H-Index: 43

Leveraging influenza virus surveillance from 2012 to 2015 to characterize the burden of respiratory syncytial virus disease in Canadian adults≥ 50 years of age hospitalized …

Open Forum Infectious Diseases

2023/7

Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada

International Journal of Infectious Diseases

2023/6/1

Treatment of COVID-19 symptoms with over the counter (OTC) medicines used for treatment of common cold and flu

2023/5/6

Ronald Eccles
Ronald Eccles

H-Index: 28

Guy Boivin
Guy Boivin

H-Index: 43

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria-and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs

Microorganisms

2023/4/22

Guy Boivin
Guy Boivin

H-Index: 43

Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series

Infection Control & Hospital Epidemiology

2023/4

Guy Boivin
Guy Boivin

H-Index: 43

Combination of diltiazem and viral polymerase inhibitors

2023/3/9

Protocol: Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

BMJ Open

2023

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

BMJ open

2023/1/1

Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice

Journal of Alzheimer's Disease

2023/12/16

Impact of COVID-19 and Vaccination During Pregnancy on Placenta-Mediated Complications (COVIGRO Study)

Journal of Obstetrics and Gynaecology Canada

2023/11/23

New mucosal bivalent live-attenuated vaccine is protective against Human Metapneumovirus and Respiratory Syncytial Virus

2023/11/2

Guy Boivin
Guy Boivin

H-Index: 43

Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled …

Vaccine

2023/10/6

The possibility of spreading herpes simplex virus type 1 via food handling and sharing

Journal of Applied Microbiology

2023/10

Guy Boivin
Guy Boivin

H-Index: 43

Julie Jean
Julie Jean

H-Index: 19

In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections

Virology

2023/9/1

Guy Boivin
Guy Boivin

H-Index: 43

Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13

The CRISPR Journal

2023/8/1

Guy Boivin
Guy Boivin

H-Index: 43

In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing

Journal of Clinical Virology

2023/8/1

Guy Boivin
Guy Boivin

H-Index: 43

See List of Professors in Guy Boivin University(Université Laval)

Co-Authors

academic-engine